certolizumab pegol antibody drug (pegylated fab' fragment). targets tnf-a; indications for use include crohn's disease, rheumato

alpha ankylosing antibody arthritis autoimmune biological biosimilar biotech biotechnology certolizumab crohn disease drug glycol immunoglobulin immunology infusion injection inn mab monoclonal necrosis nomenclature peg pegol pegylated peptide polyethylene protein psoriatic rheumatoid spondylitis tnfa tumor